ING
ING GROEP NVMarquee-fund ownership over time
This quarter's activity
New positions opened
Positions exited
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Citadel Advisors re-entered | Q3 2024(8Q snapshot) | 7Q | $16 | $30 | +90% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $16 | $30 | +90% |
| Millennium Management | Q4 2024(8Q snapshot) | 6Q | $14 | $30 | +107% |
| Point72 Asset Management re-entered | Q4 2024(8Q snapshot) | 6Q | $14 | $30 | +107% |
| Two Sigma Investments | Q2 2026(8Q snapshot) | 1Q | $29 | $30 | +0% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at ING GROEP NV. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Mar 9, 2015 — the most recent Form 4 on file — not from today.
- Form 40001209191-15-024088Mar 9, 2015
- Form 40001209191-14-069647Nov 18, 2014
- Form 40001209191-14-056777Sep 8, 2014
- Form 40001209191-14-023161Mar 26, 2014
- Form 40001181431-13-055468Oct 29, 2013
- Form 40001181431-13-031595May 30, 2013
- Form 40001181431-13-025927May 7, 2013
- Form 40001181431-12-049653Sep 10, 2012
- Form 40001181431-12-042018Jul 25, 2012
Fundamentals
XBRL · ING GROEP NVNot enough XBRL history to plot. ING GROEP NVhasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for ING GROEP NV — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 6-KFORM 6-KJun 9, 2026
- 6-KFORM 6-KJun 8, 2026
- 6-KFORM 6-KJun 2, 2026
- 6-KFORM 6-KMay 26, 2026
- 6-KFORM 6-KMay 19, 2026
- 6-KFORM 6-KMay 12, 2026
- 6-KFORM 6-KMay 5, 2026
- 6-KFORM 6-KApr 30, 2026
- 6-KFORM 6-KApr 30, 2026
- 6-KFORM 6-KApr 28, 2026
- 6-KFORM 6-KApr 24, 2026
- 6-KFORM 6-KApr 21, 2026
- 6-KFORM 6-KApr 15, 2026
- 6-KFORM 6-KApr 14, 2026
- 6-KFORM 6-KApr 7, 2026
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Two Sigma Investments | Q2 2026 | open | $29 | $30 | +0% |
| Citadel Advisors | Q4 2025 | open | $25 | $30 | +18% |
| Point72 Asset Management | Q4 2025 | open | $25 | $30 | +18% |
| Millennium Management | Q4 2024 | open | $14 | $30 | +107% |
| Point72 Asset Management | Q4 2024 | Q2 2025 | $14 | $20 | +44% |
| Citadel Advisors | Q3 2024 | Q3 2025 | $16 | $24 | +56% |
| AQR Capital Management | Q3 2024 | open | $16 | $30 | +90% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.